Six Years, One Forged Prescription: How Ruti Aga's Ban Exposes the Medical-Governance Vacuum Behind East African Road Running

There is one memory from the 2026 Tokyo Marathon I cannot shake. Ruti Aga crossed the line and, for a moment, the roar of the crowd seemed to blur — as if the entire stadium was pronouncing an unfamiliar name for the first time. She won a race in which the eyes of the crowd were searching for someone else entirely. Six years later, I read the Athletics Integrity Unit (AIU) statement issued on Thursday, and the same athlete stands at another finish line. She is 32. The ban of six years, effective from 10 September. The arithmetic is simple: a return at approximately 38. In Ethiopia's women's marathon depth, a 38-year-old returnee with a doping record is, practically speaking, unselectable. But before we explain the prescription, one thing must be straightened out, because the first wave of reporting got it wrong.

Aga has been found in violation — a sample collected after she won a half marathon in China in March tested positive for a prohibited substance. The initial reports called it a 'steroid.' Technically, that is inaccurate. Methylprednisolone is a glucocorticoid — class S9 of the WADA Prohibited List — not an anabolic steroid (S1). And what defines S9 is that it is prohibited only in-competition, by injection, oral, or rectal route. A therapeutic knee injection is entirely legal out of competition; the problem arises only if residues are present in-competition. This detail matters because the case collapsed not on steroids, but on route and timing.

What the case says — according to the AIU statement, Aga attributed the use of methylprednisolone to the treatment of a knee injury. The investigation found that the clinic named on the prescription did not exist; the 'doctor' was a family member with no medical registration; and he claimed to have used 'an old prescription pad from a former workplace' — which the clinic explicitly disowned. Three independent verification failures. The sanction arithmetic also speaks: two years for the presence violation, four years for tampering — six in total. Two years implies the panel did not find an aggravating intent element in the substance charge. Four years implies the fabricated documents were treated as fully culpable.

My real unease begins here. I have long watched the 'cheap, safe' income tier of road racing — where East African marathoners between Majors come to Asian Label races to collect appearance fees. That is the tier that has now become the AIU's highest-yield testing ground. And that is the tier where the pressure to mask injury is most acute — because injury means losing the fee. A knee glucocorticoid is the cheapest, most readily available fix. I am convinced (and this is my inference, not a documented fact) that Aga's knee problem was not an acute March event but a chronic, years-long condition — a pattern of informal treatment whose natural offspring is the urge to fabricate paperwork.

And here is the deepest irony: for the very substance against which she had a legitimate defence — timing, route, a documented medical necessity — she destroyed that defence with a forged prescription. Because S9 is prohibited only in-competition, a properly managed athlete would either hold or apply for a TUE, or observe the washout period. Aga's entourage had neither a credentialed team physician nor TUE infrastructure. The absent clinic, the unregistered practitioner — this is not a filing error; it is a portrait of a medical governance that is entirely missing. And this is not one athlete's story; it is a cluster's story. The question is not what Aga did; the question is who, on what evening, prepared which old prescription pad — and why no investigation of the agent or management is mentioned in the statement.

On performance, there is almost nothing here. No mark, no split, no field strength is recorded for the Chinese half marathon. To judge what level of 'win' that was, without a time, would be self-deception. What survives is the historical inheritance: the 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors. Note that the AIU did not say whether her earlier records would be annulled. That absence in a major case is a signal that the scope of the sanction is limited to the March race; it does not erase the record of a genuinely elite 2:18–2:20 marathoner, but it makes her commercially radioactive — in a sport where distance-running sponsorship is already thin.

My greatest worry is that this sanction will be used as a symbol of AIU rigour. I read it the other way. Six years for a glucocorticoid — a substance with no proven endurance benefit — and alongside it, a growing pile of tampering charges in the era of document verification: this tells us the enforcement frontier has shifted from 'detection' to 'paperwork verification.' But the reverse is equally valid — evidence of disproportionate enforcement against African road runners. When the athlete's defence machinery rests on agent networks and access to the language, translation, and legal aid of the investigation is limited, a six-year ban stands on the line between justice and severity.

This is where the breadth-versus-depth argument arrives — is the AIU now fighting breadth (the truth of documents and statements) rather than depth (catching substances)? Perhaps yes. But my concern is that this breadth is burying the athlete deeper rather than protecting her, because one who has no genuine medical record cannot even speak the truth — and the penalty for lying turns out heavier than the substance itself.

I still remember that morning in Tokyo 2026, when she first ran across that finish line — the roar of the crowd, that unfamiliar name turning into applause for the first time. Six years later, the same name is shut inside a file of papers. The question is not whether Aga will return — the question is whether the next runner who receives a knee injection will come, without fear, with a genuine prescription, and whether her entourage will include a doctor who writes her a TUE. Until that doctor arrives, every second Ruti Aga emerging from Ethiopia's valleys will pass through this same file.